Alnylam Pharmaceuticals, Inc. Equity-NMS: ALNY

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$257.19
Open :	$256.99
Today's high :	$258
Today's low :	$253.47
52W low :	$144.73
52W high :	$304.39
1Y :	75.98%
5Y :	98.32%
EPS(TTM): :	-2.19
Shares O/S :	129.43 M
Market cap :	33.53 B

What is the share price of Alnylam Pharmaceuticals, Inc. today?

Alnylam Pharmaceuticals, Inc. (ALNY) share price as of April 29, 2025, is $257.19. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Alnylam Pharmaceuticals, Inc.?

Yes, Indian Investors can invest in the Alnylam Pharmaceuticals, Inc. (ALNY) Share by opening an international trading account with Angel One.

How can I purchase Alnylam Pharmaceuticals, Inc. shares in India?

Purchasing Alnylam Pharmaceuticals, Inc. (ALNY) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Alnylam Pharmaceuticals, Inc. (ALNY) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Alnylam Pharmaceuticals, Inc.?

Yes, you can purchase fractional shares of Alnylam Pharmaceuticals, Inc. (ALNY) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Alnylam Pharmaceuticals, Inc.?

The market capitalization of Alnylam Pharmaceuticals, Inc. on April 29, 2025, is $52.09 B.

In which sector Alnylam Pharmaceuticals, Inc. belongs?

Alnylam Pharmaceuticals, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Alnylam Pharmaceuticals, Inc. stocks?

In order to invest in Alnylam Pharmaceuticals, Inc. (ALNY) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Alnylam Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in discovering, developing, manufacturing and commercializing novel therapeutics based on ribonucleic acid interference (RNAi). Its marketed products include AMVUTTRA (vutrisiran) for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR) with polyneuropathy in adults; ONPATTRO (patisiran) for the treatment of the polyneuropathy of hATTR amyloidosis in adults; GIVLAARI (givosiran) for the treatment of adults with acute hepatic porphyria; OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1, and Leqvio (inclisiran), which is being developed and commercialized by its partner, Novartis AG, for the treatment of adults with hypercholesterolemia or mixed dyslipidemia. The Company’s clinical development programs include Cemdisiran, Fitusiran, Zilebesiran, Elebsiran, Mivelsiran and ALN-HTT02. It is developing Cemdisiran to treat complement-mediated diseases.